Paul Saladino· MD
to my knowledge it's exclusively from breakdown of LA
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
to my knowledge it's exclusively from breakdown of LA
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
with regard to carboxyl pyrol and um macular degeneration first of all I I don't know that this is a major player Paul but it is a player like I said and there's many many arrows all coming together you know with with regard to macro degeneration but with carboxyl pyrol we actually know that um this molecule is creating autoimmunity in some people